loadpatents
name:-0.040729999542236
name:-0.016263961791992
name:-0.0052859783172607
Cooper; Martin Ian Patent Filings

Cooper; Martin Ian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cooper; Martin Ian.The latest application filed is for "novel solid forms of bendamustine hydrochloride".

Company Profile
4.9.20
  • Cooper; Martin Ian - Cambridge GB
  • Cooper; Martin Ian - Foxton GB
  • Cooper; Martin Ian - Cambridgeshire GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel Solid Forms Of Bendamustine Hydrochloride
App 20200323824 - Cooper; Martin Ian ;   et al.
2020-10-15
Solid forms of bendamustine hydrochloride
Grant 10,517,852 - Cooper , et al. Dec
2019-12-31
Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate
Grant 10,301,287 - Phiasivongsa , et al.
2019-05-28
Novel Solid Forms Of Bendamustine Hydrochloride
App 20190015390 - Cooper; Martin Ian ;   et al.
2019-01-17
Solid forms of bendamustine hydrochloride
Grant 10,039,750 - Cooper , et al. August 7, 2
2018-08-07
Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-D- ]pyrimidin-7-YL}-2-hydroxycyclopentyl) methyl sulfamate
Grant 10,016,427 - Armitage , et al. July 10, 2
2018-07-10
Solid Forms Of Cenicriviroc Mesylate And Processes Of Making Solid Forms Of Cenicriviroc Mesylate
App 20180057481 - PHIASIVONGSA; Pasit ;   et al.
2018-03-01
Novel Solid Forms Of Bendamustine Hydrochloride
App 20170071913 - Cooper; Martin Ian ;   et al.
2017-03-16
Hydrochloride Salt Of((1s,2s,4r)-4--2-hydroxycyclopentyl) Methyl Sulfamate
App 20170000792 - Armitage; Ian G. ;   et al.
2017-01-05
Solid forms of bendamustine hydrochloride
Grant 9,533,955 - Cooper , et al. January 3, 2
2017-01-03
Novel Solid Forms Of Bendamustine Hydrochloride
App 20160159748 - Cooper; Martin Ian ;   et al.
2016-06-09
Hydrochloride Salt Of((1s,2s,4r)-4--2-hydroxycyclopentyl) Methyl Sulfamate
App 20160030432 - Armitage; Ian G. ;   et al.
2016-02-04
Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d- ]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
Grant 9,187,482 - Armitage , et al. November 17, 2
2015-11-17
Lactate Salt Of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-car- Boxylic Acid(4-isopropoxyphenyl)-amide And Pharmaceutical Compositions Thereof For The Treatment Of Cancer And Other Diseases Or Disorders
App 20150133460 - Armitage; Ian ;   et al.
2015-05-14
Novel Solid Forms Of Bendamustine Hydrochloride
App 20150051258 - Cooper; Martin Ian ;   et al.
2015-02-19
Solid forms of bendamustine hydrochloride
Grant 8,883,836 - Cooper , et al. November 11, 2
2014-11-11
Novel Solid Forms Of Bendamustine Hydrochloride
App 20140187598 - Cooper; Martin Ian ;   et al.
2014-07-03
Solid forms of bendamustine hydrochloride
Grant 8,669,279 - Cooper , et al. March 11, 2
2014-03-11
Novel Solid Forms Of Bendamustine Hydrochloride
App 20130245086 - Cooper; Martin Ian ;   et al.
2013-09-19
Soluble Salts of Thieno [2,3-d] Pyrimidine Derivatives
App 20120202825 - Cooper; Martin Ian ;   et al.
2012-08-09
Novel Solid Forms Of Bendamustine Hydrochloride
App 20120071532 - Cooper; Martin Ian ;   et al.
2012-03-22
Hydrochloride Salt Of ((1s,2s,4r)-4--2-hydroxycyclopentyl)methyl Sulfamate
App 20110021544 - Armitage; Ian G. ;   et al.
2011-01-27
Lactate Salt Of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-car- Boxylic Acid(4-isopropoxyphenyl)-amide And Pharmaceutical Compositions Thereof For The Treatment Of Cancer And Other Diseases Or Disorders
App 20100273808 - Armitage; Ian ;   et al.
2010-10-28
Novel Solid Forms Of Bendamustine Hydrochloride
App 20090264488 - Cooper; Martin Ian ;   et al.
2009-10-22
Mesylate salt of an IKK inhibitor
App 20090137579 - Hicks; Frederick A. ;   et al.
2009-05-28
Salts of an IKK inhibitor
App 20090131422 - Hicks; Frederick A. ;   et al.
2009-05-21
Soluble salts of thieno[2,3-d]pyrimidine derivatives
App 20070254899 - Cooper; Martin Ian ;   et al.
2007-11-01
Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno[2,3-d]pyrimidine
App 20070254891 - Cooper; Martin Ian ;   et al.
2007-11-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed